LIGAND PHARMACEUTICAL INC (LGNXZ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 86.3 Million USD | -47.75% |
| 2022 | 165.18 Million USD | -65.33% |
| 2021 | 476.43 Million USD | -27.01% |
| 2020 | 652.76 Million USD | -10.3% |
| 2019 | 727.68 Million USD | -3.21% |
| 2018 | 751.85 Million USD | 132.87% |
| 2017 | 322.86 Million USD | 24.04% |
| 2016 | 260.29 Million USD | -2.06% |
| 2015 | 265.77 Million USD | 13.77% |
| 2014 | 233.62 Million USD | 323.99% |
| 2013 | 55.1 Million USD | -29.15% |
| 2012 | 77.77 Million USD | -26.18% |
| 2011 | 105.36 Million USD | 46.2% |
| 2010 | 72.06 Million USD | -44.45% |
| 2009 | 129.71 Million USD | -23.46% |
| 2008 | 169.46 Million USD | 28.56% |
| 2007 | 131.81 Million USD | -53.97% |
| 2006 | 286.35 Million USD | -30.61% |
| 2005 | 412.69 Million USD | 4.36% |
| 2004 | 395.43 Million USD | 3642.91% |
| 2003 | 10.56 Million USD | -62.85% |
| 2002 | 28.43 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 91.2 Million USD | -15.04% |
| 2024 Q1 | 107.34 Million USD | 24.39% |
| 2023 Q2 | 93.21 Million USD | -43.42% |
| 2023 Q1 | 164.75 Million USD | -0.26% |
| 2023 Q3 | 101.33 Million USD | 8.71% |
| 2023 Q4 | 86.3 Million USD | -14.83% |
| 2023 FY | 86.3 Million USD | -47.75% |
| 2022 Q1 | 311.99 Million USD | -34.51% |
| 2022 FY | 165.18 Million USD | -65.33% |
| 2022 Q2 | 273.92 Million USD | -12.2% |
| 2022 Q4 | 165.18 Million USD | -29.5% |
| 2022 Q3 | 234.3 Million USD | -14.46% |
| 2021 Q2 | 469.76 Million USD | -14.48% |
| 2021 Q1 | 549.28 Million USD | -15.85% |
| 2021 FY | 476.43 Million USD | -27.01% |
| 2021 Q4 | 476.43 Million USD | 3.22% |
| 2021 Q3 | 461.59 Million USD | -1.74% |
| 2020 Q4 | 652.76 Million USD | 18.76% |
| 2020 Q1 | 524.02 Million USD | -27.99% |
| 2020 Q2 | 547.93 Million USD | 4.56% |
| 2020 Q3 | 549.62 Million USD | 0.31% |
| 2020 FY | 652.76 Million USD | -10.3% |
| 2019 Q1 | 834.01 Million USD | 19.16% |
| 2019 Q4 | 727.68 Million USD | 4.42% |
| 2019 Q3 | 696.89 Million USD | -8.35% |
| 2019 FY | 727.68 Million USD | -3.21% |
| 2019 Q2 | 760.38 Million USD | -8.83% |
| 2018 Q4 | 699.88 Million USD | -50.23% |
| 2018 Q2 | 1.23 Billion USD | 380.98% |
| 2018 Q1 | 257.49 Million USD | 2.03% |
| 2018 Q3 | 1.4 Billion USD | 13.55% |
| 2018 FY | 751.85 Million USD | 132.87% |
| 2017 Q2 | 230.61 Million USD | -0.14% |
| 2017 FY | 322.86 Million USD | 24.04% |
| 2017 Q4 | 252.37 Million USD | 6.23% |
| 2017 Q3 | 237.57 Million USD | 3.02% |
| 2017 Q1 | 230.94 Million USD | 0.09% |
| 2016 Q3 | 230.47 Million USD | 2.49% |
| 2016 FY | 260.29 Million USD | -2.06% |
| 2016 Q4 | 230.73 Million USD | 0.11% |
| 2016 Q2 | 224.88 Million USD | 1.59% |
| 2016 Q1 | 221.36 Million USD | -3.56% |
| 2015 Q2 | 235.7 Million USD | 2.11% |
| 2015 Q1 | 230.82 Million USD | -1.2% |
| 2015 FY | 265.77 Million USD | 13.77% |
| 2015 Q4 | 229.53 Million USD | 0.01% |
| 2015 Q3 | 229.51 Million USD | -2.63% |
| 2014 Q3 | 229.5 Million USD | 524.3% |
| 2014 Q2 | 36.76 Million USD | -9.16% |
| 2014 Q1 | 40.47 Million USD | -26.55% |
| 2014 FY | 233.62 Million USD | 323.99% |
| 2014 Q4 | 233.62 Million USD | 1.8% |
| 2013 FY | 55.1 Million USD | -29.15% |
| 2013 Q2 | 60.3 Million USD | -11.01% |
| 2013 Q3 | 56.86 Million USD | -5.71% |
| 2013 Q1 | 67.76 Million USD | -12.87% |
| 2013 Q4 | 55.1 Million USD | -3.1% |
| 2012 Q1 | 91.5 Million USD | -13.15% |
| 2012 FY | 77.77 Million USD | -26.18% |
| 2012 Q2 | 85.34 Million USD | -6.72% |
| 2012 Q3 | 76.27 Million USD | -10.64% |
| 2012 Q4 | 77.77 Million USD | 1.97% |
| 2011 Q3 | 111.75 Million USD | -1.77% |
| 2011 Q1 | 120.8 Million USD | 67.63% |
| 2011 Q2 | 113.76 Million USD | -5.82% |
| 2011 Q4 | 105.36 Million USD | -5.72% |
| 2011 FY | 105.36 Million USD | 46.2% |
| 2010 Q1 | 123.13 Million USD | -5.08% |
| 2010 Q2 | 116.59 Million USD | -5.31% |
| 2010 Q3 | 113.66 Million USD | -2.52% |
| 2010 FY | 72.06 Million USD | -44.45% |
| 2010 Q4 | 72.06 Million USD | -36.6% |
| 2009 FY | 129.71 Million USD | -23.46% |
| 2009 Q4 | 129.71 Million USD | 9.71% |
| 2009 Q3 | 118.23 Million USD | -11.16% |
| 2009 Q2 | 133.09 Million USD | -6.23% |
| 2009 Q1 | 141.94 Million USD | -16.24% |
| 2008 Q4 | 169.46 Million USD | 27.52% |
| 2008 Q3 | 132.89 Million USD | 3.29% |
| 2008 Q2 | 128.65 Million USD | -0.56% |
| 2008 Q1 | 129.38 Million USD | -1.84% |
| 2008 FY | 169.46 Million USD | 28.56% |
| 2007 Q2 | 181.89 Million USD | -60.03% |
| 2007 Q3 | 172.88 Million USD | -4.95% |
| 2007 Q4 | 131.81 Million USD | -23.76% |
| 2007 Q1 | 455.06 Million USD | 58.92% |
| 2007 FY | 131.81 Million USD | -53.97% |
| 2006 Q2 | 512.08 Million USD | 2.27% |
| 2006 Q4 | 286.35 Million USD | -39.17% |
| 2006 FY | 286.35 Million USD | -30.61% |
| 2006 Q3 | 470.71 Million USD | -8.08% |
| 2006 Q1 | 500.7 Million USD | 21.33% |
| 2005 Q3 | 402.11 Million USD | 2.64% |
| 2005 Q4 | 412.69 Million USD | 2.63% |
| 2005 FY | 412.69 Million USD | 4.36% |
| 2005 Q1 | 394.86 Million USD | -0.15% |
| 2005 Q2 | 391.76 Million USD | -0.78% |
| 2004 Q2 | 237.31 Million USD | 1.5% |
| 2004 Q1 | 233.81 Million USD | 0.0% |
| 2004 Q4 | 395.43 Million USD | 0.0% |
| 2004 FY | 395.43 Million USD | 3642.91% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q1 | 203.15 Million USD | 151.0% |
| 2003 Q2 | 199.87 Million USD | -1.61% |
| 2003 FY | 10.56 Million USD | -62.85% |
| 2003 Q3 | 210.2 Million USD | 5.17% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | 28.43 Million USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | 37.36 Million USD | 0.0% |
| 2002 Q4 | 80.93 Million USD | 116.64% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3.15 Million USD | -2636.902% |
| Allstar Health Brands, Inc. | 9.3 Million USD | -827.625% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | -62.919% |
| Café Serendipity Holdings, Inc. | 1.31 Million USD | -6448.976% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 543.26 Thousand USD | -15786.044% |
| HealthWarehouse.com, Inc. | 7.21 Million USD | -1096.215% |
| MedGen, Inc. | 43.63 USD | -197806455.123% |
| Omni Health, Inc. | 1.94 Million USD | -4344.901% |
| Oxford Investments Holdings Inc. | 1.01 Million USD | -8384.786% |
| Pineapple, Inc. | 10.61 Million USD | -712.88% |
| ScripsAmerica, Inc. | 9.16 Million USD | -841.433% |